Marksans Pharma Limited has informed the Exchange regarding a press release dated August 22, 2023, titled "Receipt of USFDA approval for Guaifenesin Extended-Release Tablets (OTC)".
Press Release Aug 22 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Earlier from Marksans Pharma
- Press Release Aug 11 2023
- Press Release Aug 07 2023
- Press Release Jul 12 2023
- Press Release May 30 2023
- Press Release Apr 19 2023
Later from Marksans Pharma
- Press Release Oct 03 2023
- Press Release Nov 01 2023
- Press Release Nov 03 2023
- Press Release Nov 06 2023
- Press Release Nov 09 2023
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma